Synthesis and biological properties of 7α-cyano derivatives of the (17α,20E/Z)-[125I]iodovinyl- and 16α-[ 125I]iodo-estradiols

Steroids

Volumn 68, Issue 14, 2003, Pages 1189-1200

  Ali, Hasrat ^a   Rousseau, Jacques ^a   Paquette, Benoit ^a   Dubé, Charlotte ^a   Marko, Bernadette ^a   Van Lier, Johan E ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

(17 ,20E Z) iodovinylestradiol derivatives; 16 Iodoestradiol; 7 Cyanoestradiol derivatives; Breast tumor imaging

Indexed keywords

BORANE DERIVATIVE; ESTRADIOL DERIVATIVE; ESTROGEN RECEPTOR; HALOGEN; IODINE DERIVATIVE; PROTEIN PS2; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; VINYL DERIVATIVE;

ARTICLE; BREAST CARCINOMA; CATALYST; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; ISOMERISM; ISOTOPE LABELING; PROTEIN FUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOSPECIFICITY; TISSUE DISTRIBUTION; UTERUS;

EID: 0345687898     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2003.09.005     Document Type: Article

References (31)

1. Katzenellenbogen JA. Receptor imaging of tumors (non-peptide). In: Welch MJ, Redvaly CS, editors. Handbook of radiopharmaceuticals. West Sussex: Wiley; 2003. p. 715-50.
2. Katzenellenbogen JA, Heiman DF, Carlson KE, Lloyd JE. In vivo and in vitro steroid receptor assays in the design of estrogen pharmaceuticals. In: Eckelman WC, editor. Receptor binding radiotracers. Boca Raton, FL: CRC Press; 1982. p. 93-126.
3. Hochberg R.B. Iodine-125-labeled estradiol: a gamma emitting analog of estradiol that binds to the estrogen receptor. Science. 205:1979;1138-1140.
4. 125I I]iodo-11β-methoxy-19-norpregna-1,3,5(10),20-tetraene-3,17- diol (17α-(iodovinyl)estradiol derivatives) as high specific activity potential radiopharmaceuticals J. Med. Chem. 27:1984;1287-1291.
5. 125I ]iodo-19-norpregna-1,3,5(10),20-tetraene-3,17-diol J. Med. Chem. 31:1988;1946-1950.
6. Raynaud J.P., Ojasoo T. The design and use of sex-steroid antagonists. J. Steroid. Biochem. 25:1986;811-833.
7. Gantchev T.G., Ali H., van Lier J.E. Quantitative structure-activity relationship/comparative molecular field analysis (QSAR/CoMFA) for receptor binding properties of halogenated estradiol derivatives. J. Med. Chem. 37:1994;4164-4176.
8. 123I ]Iodovinyl-11β-methoxyestradiol (MIVE2) - part II. Preliminary results in patients with breast carcinoma J. Nucl. Med. Biol. Part 1B. 19:1992;263-267.
9. Rijks L.J.M., Bakker P.J.M., van Tienhoven G., Noorduyn L.A., Boer G.J., Rietbroek R.C.et al. Imaging of estrogen receptors in primary and metastatic breast cancer patients with Iodine-123-labeled Z-MIVE. J. Clin. Oncol. 15:1997;2536-2545.
10. 123I ]iodovinylestradiol (MIVE) in healthy volunteers and breast cancer patients J. Nucl. Med. 40:1999;1728-1736.
11. 99mTc -MIBI in the characterization of breast tumors J. Nucl. Med. 41:2000;1324-1331.
12. Quivy J., Leclercq G., Deblaton M., Henrot P., Velings N., Norberg B.et al. Synthesis, structure and biological properties of Z-17α-(2-iodovinyl)- 11β-chloromethyl estradiol-17β (Z-CMIV), a high affinity ligand for the characterization of estrogen receptor-positive tumors. J. Steroid Biochem. Mol. Biol. 59:1996;103-117.
13. 18F -labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceutical Steroids. 67:2002;765-775.
14. Kalvoda J., Krahnenbuhl C., Desaulles P.A., Anner G.A. 7-Alpha-methylestrogens. Helv. Chim. Acta. 50:1967;281-288.
15. Levesque C., Merand Y., Dufour J.M., Labrie C., Labrie F. Synthesis and biological activity of new halo-steroidal antiestrogens. J. Med. Chem. 34:1991;1624-1630.
16. Dasilva J.N., van Lier J.E. Synthesis and structure-affinity of a series of 7α-undecylestradiol derivatives: a potential vector for therapy and imaging of estrogen receptor-positive cancers. J. Med. Chem. 33:1990;430-434.
17. Ali H., van Lier J.E. Synthesis of nitrile derivatives of estrogens. Bioorg. Med. Chem. Lett. 12:2002;2847-2849.
18. 125I ]- 16α̃ -iodoestradiol: effect on estrogen receptor-mediated target tissue uptake J. Med. Chem. 36:1993;264-271.
19. Thibodeau P.A., Bissonnette N., Bedard S.K., Hunting D., Paquette B. Induction by estrogens of methotrexate resistance in MCF-7 breast cancer cells. Carcinogenesis. 19:1998;1545-1552.
20. Rijks L.J., Boer G.J., Endert E., de Bruin K., van den Bos J.C., van Doremalen P.A.et al. The stereoisomers of 17α-[123I]iodovinyloestradiol and its 11β-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats. Eur. J. Nucl. Med. 23:1996;295-307.
21. Brown A.M., Jeltsch J.M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA. 81:1984;6344-6348.
22. Waynforth HB. Methods of obtaining body fluids. In: Waynforth HB, editor. Experimental and surgical technique in the rat. London: Academic Press; 1980. p. 62-86.
23. Howell DC. Describing and exploring data. In: Crockett C, editor. Statistical methods for psychology. Duxbury Pacific Grove, CA, USA; 2002. p. 15-72.
24. Nozaki K., Oshima K., Uchimoto K. Et3B-induced radical addition of R3SnH to acetylenes and its application to cyclization reaction. J. Am. Chem. Soc. 109:1987;2547-2549.
25. Johnson W.S., Johns W.F. 14-Isoestrone methyl ether and its identity with totally synthetic material. J. Am. Chem. Soc. 79:1957;2005-2009.
26. Heiman D.F., Senderoff S.G., Katzenellenbogen J.A., Neeley R.J. Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. J. Med. Chem. 23:1980;994-1002.
27. Longcope C., Arunachalam T., Rafkind I., Caspi E. Biologic activity of the iodoestrogens and their use in breast cancer. Adv. Exp. Med. Biol. 138:1981;191-210.
28. 125I ]iodo-19-norpregna-1, 3,5(10),20-tetraene-3,17-diols J. Med. Chem. 34:1991;854-860.
29. Lippman M.E., Do H.M., Hochberg R.B. Specific estrogen receptor binding and biological effects of 16α-iodoestradiol on human breast cancer cells. Cancer Res. 41:1981;3150-3154.
30. Scharl A., Beckmann M.W., Artwohl J.E., Kullander S., Holt J.A. Rapid liver metabolism, urinary and biliary excretion, and enterohepatic circulation of 16α-radioiodo-17β-estradiol. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;1235-1240.
31. Levesque C., Merand Y., Dufour J.M., Labrie C., Labrie F. Synthesis and biological activity of new halo-steroidal antiestrogens. J. Med. Chem. 34:1991;1624-1630.